Simple Risk Score May Guide CRC Screening Before Age 45: Daily Dose
Your daily dose of the clinical news you may have missed.
Alzheimer Disease in 2025: American Perspectives
US adults want to know if they have Alzheimer disease and early, when treatment may slow it down; they are even willing to risk participation in trials of new drugs. Read more.
Telehealth in Pediatric Primary Care Linked to Lower Antibiotic Prescribing for Respiratory Infections
Telehealth visits in pediatric primary care were linked to lower antibiotic prescribing rates for respiratory infections compared with in-person visits.
Amyloid and Tau Biomarkers of Alzheimer Disease Found in Individuals with Other Dementias
Biomarkers in a pattern characteristic of Alzheimer pathology were identified in unspecified dementia, Parkinson dementia, and frontotemporal dementia.
FDA-Cleared AI Lung Sound Tool Extends Specialist Diagnostics to Primary Care, Home
The FDA has cleared TytoCare’s AI-powered Tyto Insights for detecting rhonchi, the third lung sound alongside wheeze and crackles.
Switching Anti-CGRP Monoclonal Antibody Therapy in Nonresponders with Migraine May Reduce Monthly Headache Days
Subgroup analyses found no significant difference in efficacy based on change in therapeutic action (ie, CGRP vs its receptor), doses, or intertreatment interval.
Dupilumab Effective, Safe for Severe Pediatric Atopic Dermatitis: Daily Dose
Clinical Pearls from 2025 ACP Internal Medicine Meeting
Expert insights on PAD prevention, boosting colon cancer screening, and expanding obesity treatment options.
Depression & Anxiety in Adults with Chronic Pain: A Meta-Analysis Review
Approximately 40% of adults with chronic pain have comorbid anxiety and/or depression, underscoring the importance of routine screening in this population.
AI Detects Nearly One-Third of Breast Cancers Previously Undetected by Radiologists on DBT Imaging
The AI program also correctly identified 90% of true positive cases, according to new data presented at the Society for Breast Imaging's annual symposium.
Moderate Preterm Birth Linked to Cognitive Deficits in Childhood in New Study
Children born before 34 weeks of gestation exhibited significant cognitive deficits by age 9-10, independent of genetic and socioeconomic factors, reported researchers.
Metabolic Syndrome Linked to Risk of Young Onset Dementia
Authors found a dose-response relationship between MetS and dementia onset in the 4th decade; in those with all 5 components, risk of dementia was increased by 77%.
Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose
Upadacitinib Found Effective in Achieving Remission in Crohn Disease, Including Biologic-Experienced Patients
In a real-world study of patients with Crohn disease, upadacitinib achieved 52.1% clinical remission at 12 weeks and 42.7% endoscopic remission at 6 months, with no new safety concerns reported.
Endemic Measles is a Clear and Present Danger, According to Stanford University Modeling Study
At current vaccination rates, measles could become endemic in the US again within 21 years; the threat extends to rubella, polio, and diphtheria, the study found.
Postpartum Hormonal Contraceptive Use Linked to Increased Risk of Depression
The increased risk of depression when oral contraceptives were started following childbirth was "instantaneous," researchers wrote, and was ~50% greater than nonuse.
Precision Obesity Medicine Breakthroughs To Lead DDW 2025 Presentations from Phenomix Sciences
Phenomix will showcase new data on prediction of adverse events to GLP-1 RA therapy, a new obesity sub-phenotype, and approaches to improve surgical outcomes.
Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose
The Role for CGM in Glycemic Management Will Continue to Expand, Including in Prediabetes, Expert Says
CGM is now standard of care in T1D and evidence is solid for a role in insulin-treated T2D; Thomas Martens, MD, shares thoughts on CGM growth in the next 3-5 years.
New-Onset Type 2 Diabetes Tied to Higher Risk of Specific Obesity-Related Cancers
New data to be presented at ECO 2025 shows new-onset T2D is linked to increased risk of liver, pancreatic, and bowel cancers, but not endometrial or post-menopausal breast cancer.
